BNXTF
Price
$0.60
Change
-$0.00 (-0.00%)
Updated
Oct 17 closing price
Capitalization
71.6M
Intraday Buy/Sell Signals
ESAIY
Price
$7.55
Change
+$0.13 (+1.75%)
Updated
Oct 17 closing price
Capitalization
8.47B
Intraday Buy/Sell Signals
Interact to see
Advertisement

BNXTF vs ESAIY

Header iconBNXTF vs ESAIY Comparison
Open Charts BNXTF vs ESAIYBanner chart's image
BIONXT SOLUTIONS
Price$0.60
Change-$0.00 (-0.00%)
Volume$13.11K
Capitalization71.6M
Eisai
Price$7.55
Change+$0.13 (+1.75%)
Volume$66.57K
Capitalization8.47B
BNXTF vs ESAIY Comparison Chart in %
BNXTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ESAIY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BNXTF vs. ESAIY commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BNXTF is a Hold and ESAIY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 18, 2025
Stock price -- (BNXTF: $0.60 vs. ESAIY: $7.55)
Brand notoriety: BNXTF and ESAIY are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: BNXTF: 244% vs. ESAIY: 89%
Market capitalization -- BNXTF: $71.6M vs. ESAIY: $8.47B
BNXTF [@Pharmaceuticals: Generic] is valued at $71.6M. ESAIY’s [@Pharmaceuticals: Generic] market capitalization is $8.47B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.85B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.93B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BNXTF’s FA Score shows that 0 FA rating(s) are green whileESAIY’s FA Score has 1 green FA rating(s).

  • BNXTF’s FA Score: 0 green, 5 red.
  • ESAIY’s FA Score: 1 green, 4 red.
According to our system of comparison, ESAIY is a better buy in the long-term than BNXTF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BNXTF’s TA Score shows that 3 TA indicator(s) are bullish while ESAIY’s TA Score has 4 bullish TA indicator(s).

  • BNXTF’s TA Score: 3 bullish, 6 bearish.
  • ESAIY’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ESAIY is a better buy in the short-term than BNXTF.

Price Growth

BNXTF (@Pharmaceuticals: Generic) experienced а -7.00% price change this week, while ESAIY (@Pharmaceuticals: Generic) price change was +2.30% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.79%. For the same industry, the average monthly price growth was +4.23%, and the average quarterly price growth was +51.45%.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.79% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ESAIY($8.47B) has a higher market cap than BNXTF($71.6M). BNXTF YTD gains are higher at: 137.991 vs. ESAIY (12.018). ESAIY has higher annual earnings (EBITDA): 104B vs. BNXTF (-4.93M). ESAIY has more cash in the bank: 266B vs. BNXTF (4.24K). BNXTF has less debt than ESAIY: BNXTF (7.06M) vs ESAIY (188B). ESAIY has higher revenues than BNXTF: ESAIY (789B) vs BNXTF (21.7K).
BNXTFESAIYBNXTF / ESAIY
Capitalization71.6M8.47B1%
EBITDA-4.93M104B-0%
Gain YTD137.99112.0181,148%
P/E RatioN/A27.84-
Revenue21.7K789B0%
Total Cash4.24K266B0%
Total Debt7.06M188B0%
FUNDAMENTALS RATINGS
BNXTF: Fundamental Ratings
BNXTF
OUTLOOK RATING
1..100
22
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BNXTFESAIY
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
67%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
67%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 8 days ago
70%
Bullish Trend 17 days ago
62%
Declines
ODDS (%)
N/A
Bearish Trend 8 days ago
70%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
BNXTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ESAIY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARCAY54.55N/A
N/A
Arcadis NV
BETRF0.04N/A
N/A
BETTERLIFE PHARMA INC.
SFRGF5.50N/A
N/A
Salvatore Ferragamo S.P.A.
PRYMY51.34-0.78
-1.50%
Prysmian S.P.A.
LOMLF0.19-0.02
-8.90%
Lion One Metals Ltd.

BNXTF and

Correlation & Price change

A.I.dvisor tells us that BNXTF and TAK have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BNXTF and TAK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BNXTF
1D Price
Change %
BNXTF100%
-0.23%
TAK - BNXTF
32%
Poorly correlated
+1.15%
SNOA - BNXTF
29%
Poorly correlated
-6.17%
SDZXF - BNXTF
29%
Poorly correlated
+0.08%
ALVO - BNXTF
13%
Poorly correlated
-0.34%
ESAIY - BNXTF
11%
Poorly correlated
+1.75%
More

ESAIY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ESAIY has been loosely correlated with SGIOY. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ESAIY jumps, then SGIOY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ESAIY
1D Price
Change %
ESAIY100%
+1.75%
SGIOY - ESAIY
37%
Loosely correlated
+0.50%
TAK - ESAIY
36%
Loosely correlated
+1.15%
ESALF - ESAIY
26%
Poorly correlated
N/A
OPTHF - ESAIY
21%
Poorly correlated
-1.12%
BNXTF - ESAIY
11%
Poorly correlated
-0.23%
More